Mani Mohindru - Net Worth and Insider Trading
Mani Mohindru Net Worth
The estimated net worth of Mani Mohindru is at least $5,947 dollars as of 2024-11-13. Mani Mohindru is the CFO & Chief Strategy Officer of Cara Therapeutics Inc and owns about 17,441 shares of Cara Therapeutics Inc (CARA) stock worth over $5,947. Details can be seen in Mani Mohindru's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mani Mohindru has not made any transactions after 2019-12-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mani Mohindru
Mani Mohindru Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mani Mohindru owns 4 companies in total, including Cara Therapeutics Inc (CARA) , Curis Inc (CRIS) , and Cardiff Oncology Inc (CRDF) among others .
Click here to see the complete history of Mani Mohindru’s form 4 insider trades.
Insider Ownership Summary of Mani Mohindru
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2019-12-04 | CFO & Chief Strategy Officer |
| CRIS | Curis Inc | 2016-01-19 | Sr. VP & Corp. Strategy & IR |
| CRDF | Cardiff Oncology Inc | 2021-06-10 | director |
 | | 2020-12-16 | director |
Mani Mohindru Latest Holdings Summary
Mani Mohindru currently owns a total of 1 stock. Mani Mohindru owns 17,441 shares of Cara Therapeutics Inc (CARA) as of December 4, 2019, with a value of $5,947.
Latest Holdings of Mani Mohindru
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CARA | Cara Therapeutics Inc | 2019-12-04 | 17,441 | 0.34 | 5,947 |
Holding Weightings of Mani Mohindru
Mani Mohindru Form 4 Trading Tracker
According to the SEC Form 4 filings, Mani Mohindru has made a total of 1 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 4,755 shares on December 4, 2019, which brought Mani Mohindru around $81,073.
Insider Trading History of Mani Mohindru
- 1
Mani Mohindru Trading Performance
Mani Mohindru Ownership Network
Ownership Network List of Mani Mohindru
Ownership Network Relation of Mani Mohindru
Mani Mohindru Owned Company Details
What does Cara Therapeutics Inc do?
Who are the key executives at Cara Therapeutics Inc?
Mani Mohindru is the CFO & Chief Strategy Officer of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .
Cara Therapeutics Inc (CARA) Insider Trades Summary
Over the past 18 months, Mani Mohindru made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 60,412 shares made by Christopher Posner , a net sale of 5,476 shares made by Joana Goncalves , and a net sale of 5,236 shares made by Scott Terrillion .
In summary, during the past 3 months, insiders sold 3,668 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 3,668 shares. During the past 18 months, 74,117 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 74,117 shares.
Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cara Therapeutics Inc Insider Transactions
Mani Mohindru Mailing Address
Above is the net worth, insider trading, and ownership report for Mani Mohindru. You might contact Mani Mohindru via mailing address: C/o Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, Stamford Ct 06902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
